about
Deception in research on the placebo effectAre racial and ethnic minorities less willing to participate in health research?Broad Consent for Research With Biological Samples: Workshop ConclusionsQuantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studiesDoes random treatment assignment cause harm to research participants?Assent in research: the voices of adolescentsThe accuracy of surrogate decision makers: a systematic review.Three steps to protecting pediatric research participants from excessive risksHow should treatment decisions be made for incapacitated patients, and why?Comparative effectiveness research: what to do when experts disagree about risks.Benefits and burdens of participation in a longitudinal clinical trialBroad versus blanket consent for research with human biological samples.Should protections for research with humans who cannot consent apply to research with nonhuman primates?Do U.S. regulations allow more than minor increase over minimal risk pediatric research? Should they?What should be disclosed to research participants?Making treatment decisions for oneself: weighing the value.Which benefits of research participation count as 'direct'?Evaluating the risks of clinical research: direct comparative analysis.Using data to improve surrogate consent for clinical research with incapacitated adults.Empirical evaluation of the need for 'on-going consent' in clinical research.The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges.Which alternatives should investigators disclose to research subjects?When do the federal regulations allow placebo-controlled trials in children?"Targeted" consent for pragmatic clinical trialsHow do institutional review boards apply the federal risk and benefit standards for pediatric research?Institutional review board practices regarding assent in pediatric research.Can we ensure that all research subjects give valid consent?Shared medical decision-making: considering what options to present based on an ethical analysis of the treatment of brain tumors in very young childrenInvolving Communities in Deciding What Benefits They Receive in Multinational Research.Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit.Views of adolescents and parents on pediatric research without the potential for clinical benefitResearch involving wards of the state: protecting particularly vulnerable childrenProtections for clinical trials in low and middle income countries need strengthening not weakeningOne-time general consent for research on biological samplesConsiderations in the evaluation and determination of minimal risk in pragmatic clinical trials.Informed consent for research and authorization under the Health Insurance Portability and Accountability Act Privacy Rule: an integrated approach.Hematopoietic stem cell transplant research with pediatric donors: when can institutional review boards approve it?One-time general consent for research on biological samples: is it compatible with the health insurance portability and accountability act?Is it possible to protect pediatric research subjects without blocking appropriate research?Disclosure of incidental findings from next-generation sequencing in pediatric genomic research
P50
Q24810456-3BC258AE-81F7-45A9-A249-46B5315F4A18Q24814743-8DD966EB-7CCD-4029-8AFC-C50AF147EA8CQ28602677-5787A882-1AB6-4B91-A838-2535091B2AFFQ28647898-5E4D90B3-4A64-4814-A6EB-461C711D7494Q28768704-B9C5C1B8-8E50-43F4-8D67-2943E16FECBBQ30405510-EBE36337-0FE0-4EFC-ACCE-3E515CBF95A3Q33236318-92A90712-EB6A-4892-BC22-AEF4E73E188BQ33259163-57D84DF0-B776-4C37-A27C-B73842C49B8CQ33280132-F9E15DD6-1CAD-41C6-B490-486F6EB448BFQ33815198-9B4FE89E-22FB-4050-9650-86AF26DB2222Q33905620-82EF42FC-A029-4068-8810-12BBDB894A9CQ33922117-784221D0-FFFE-4DA4-A6D7-EA60555EA0E8Q33925142-531376FD-87AC-4564-BFF1-4115243795CBQ34081839-1E8FA037-5B78-4D83-A817-CE7C9D768B43Q34131719-CB5AA43F-7112-4FF0-8ECB-95E012E6AAC4Q34132266-7B3F9CD2-4E79-4D75-97C8-BDA15F1F7525Q34155560-2FE682EB-A98E-4C3C-A153-8A966A6916F5Q34171698-E0C65532-1DCB-4343-954D-BE46C6EA2D73Q34260794-69BAE94C-CD08-4472-87B1-CA7B4BF470E1Q34372637-1F433BE0-C9A9-4670-813F-5CE5BC2A9FA4Q34373442-5D0E6492-381E-4EBD-A2F6-080989809875Q34404662-7A29A922-E429-437C-B9FD-00699F391C9AQ35065480-674B8071-848C-4D1A-B74B-7A7A6E1E2025Q35396652-FE8DCFCE-10D6-4E27-A108-DC4CED1F829EQ35640745-9D61A516-BCD1-4111-992A-5D8FEFF7D870Q35790114-3E95CE09-DAAA-4C67-A4E9-350E0EA735EFQ35943625-FB566EB7-C127-4CD5-979B-A149B57C61F7Q36028391-EF2F5575-8EB2-4D07-B1A7-19E6566BCB76Q36069859-D0810F6E-23AC-4400-9CD6-E5C47687D44DQ36232638-9A1033E5-78B9-4005-B4B6-69A98355B2C7Q36277603-E9226E31-9DE1-4C6C-B450-A84222AECF1FQ36385929-F255FD03-0273-45A5-80C3-B8B8EE5EEABCQ36396604-0C8B04DF-6F74-4240-9ED0-9E62585848DEQ36412166-2320EB71-EFC5-4498-8C4E-081B483C138EQ36436428-B5C9C8AF-3FE7-4F55-A793-C6DA077D3EDAQ36466857-EA88CC1F-3671-4B0E-A022-EB9E32DD4E4BQ36516367-B9F398F9-2CC9-480B-8A7B-8005AD4ED5FDQ36545655-0E1EB3F5-CB0E-4ACE-ADE0-A4A072FAE88DQ36570444-1DB43CE2-F95C-4118-BA22-63CD869F597EQ36637088-AC0D6F86-FC87-49BE-BC5C-0977BD80F31E
P50
name
David Wendler
@en
type
label
David Wendler
@en
prefLabel
David Wendler
@en